After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU.

Its key assets include product candidates for Duchenne muscular dystrophy (DMD), Friedreich’s ataxia, and BAG3 mediated dilated cardiomyopathy, among others. Once combined, the next step is to ...

May 27, 2025 — A new study suggests that boys who become overweight in their early teens risk damaging the genes of their future children, increasing their chances ...

June 14, 2025 — Rutgers scientists have uncovered a tug-of-war inside the brain between hunger and satiety, revealing two newly mapped neural circuits that battle over when to eat and when to ...